Skip navigation

Recent Enforcement Updates • Risk-based Decision Making • Navigation of Global Requirements

September 25-26, 2018
  • Silver Spring, MD

CBI’s Life Sciences Recalls, Returns & Removals Summit brings together professionals in the life sciences industry with responsibilities in the recall process and product return operations. Through compelling and dynamic content, this conference delves into how to mitigate critical challenges and utilize risk-based decision making in recalls, as well as best practices for maximizing return efficiencies.

Featuring targeted content for prescription drug and OTC manufacturers and medical device and diagnostic companies, this robust program led by industry thought leaders helps drive solution-oriented discussions and present key insights on the most pressing challenges facing recalls and returns professionals.

In this 2-Day Conference, Join Your Peers
to Learn and Share Concepts and
Ideas on the Following Topics:

  • Discuss new features to FDA website and enforcement reports
  • Navigate and understand the global recall and returns space
  • Re-examine the ORA program alignment and how the restructuring has impacted industry
  • Manage automation to effectively return recalled products
  • Reduce cybersecurity concerns and vulnerabilities in devices
  • Examine the implementation of UDIs
  • Guidelines for a complete initial report
  • Effectively complete field action decisions and health hazard evaluations

Previous Attendee Acclaim:

This meeting provided me with a good basis on
key points for a successful recall.

Clinical Risk Coordinator, Care Fusion

Strong FDA representation and engagement along with
great participant discussion.

Director, Post-Approval Quality, Actavis

The industry expertise at this conference is impressive
and represents ‘best of class’ practices.

Legal Counsel, Philips Healthcare

Valuable, actionable information from the FDA.
Best ever.

Senior Manager, Ikaria Inc.